Abstract
The convergence of microelectromechanical systems (MEMS) and nanomaterials is transforming healthcare by enabling breakthroughs in diagnostics, drug delivery, and biosensing. This synergistic integration offers unprecedented precision, miniaturization, and biocompatibility, overcoming critical challenges in detecting disease markers and delivering therapies. MEMS-based devices, when combined with nanomaterials, achieve heightened sensitivity and specificity, allowing for early diagnosis and targeted treatments across various medical applications. From cancer detection to neurotransmitter monitoring for mental health management, this fusion holds immense potential in advancing personalized medicine. As research in this domain continues to evolve, MEMS-nanomaterial technologies are poised to significantly enhance healthcare outcomes by improving diagnostic accuracy, treatment efficacy, and patient well-being. This review discusses recent advances, key challenges, and future perspectives on the role of MEMS and nanotechnology in shaping the future of healthcare innovation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
